Skip to main content
Signal8

Mendelson Daniel Newman

SEC insider (Form 3/4/5 filer). CIK 0001327897. Director at CHAMPIONS ONCOLOGY, INC. (CSBR). 2 reported Form 4/5 transactions since Sep 2024; latest on Nov 5, 2025. Located in HACKENSACK, NJ.

Companies Mendelson Daniel Newman has filed insider reports for

  • CHAMPIONS ONCOLOGY, INC. (CSBR): Director
Mendelson Daniel Newman profile photo

Mendelson Daniel Newman

CIK: 0001327897

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CHAMPIONS ONCOLOGY, INC. logo
CSBR

CHAMPIONS ONCOLOGY, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • CHAMPIONS ONCOLOGY, INC. logo
    CSBR

    CHAMPIONS ONCOLOGY, INC.

    Nov 5, 2025
    Award

    Option to purchase Common Stock

    Direct
    13.8K shares at avg. $6.80-
  • CHAMPIONS ONCOLOGY, INC. logo
    CSBR

    CHAMPIONS ONCOLOGY, INC.

    Nov 12, 2024
    Award

    Option to purchase Common Stock

    Direct
    21.6K shares at avg. $4.64-

1-2 of 2